Skip to main content

Table 2 Bleeding characteristics of study subjects

From: Efficacy of a novel hemostatic adhesive powder in patients with upper gastrointestinal tumor bleeding

Variables Total enrolled patients
(n = 41)
UI-EWD monotherapy
(n = 23)
Location of the tumor bleeding, n (%)   
Esophagus 3 (7.3) 2 (8.7)
Stomach 33 (80.5) 20 (87.0)
Fundus and cardia 2 (4.9) 1 (4.3)
Body 16 (39.0) 9 (39.1)
Antrum 15 (36.6) 10 (43.6)
Duodenum 5 (12.2) 1 (4.3)
Forrest classification, n (%)   
Ia 3 (7.3) 0 (0.0)
Ib 38 (92.7) 23 (100.0)
Tumor size (cm)§ 5 (1–15) 5 (1–17)
The treatment modality, n (%)   
UI-EWD only 23 (56.1) 23 (100.0)
Coagraspher with UI-EWD 9 (22.0)  
APC with UI-EWD 4 (9.8)  
Hemoclipping with UI-EWD 3 (7.3)  
Epinephrine injection with UI-EWD 2 (4.9)  
  1. APC, argon plasma coagulation
  2. §, median (range)